Press Releases

Date	Title	View
08/19/19	Summary Toggle American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)	PDF Version
08/19/19	Summary Toggle Horizon Therapeutics plc to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference	PDF Version
08/14/19	Summary Toggle Horizon Therapeutics plc Collaborates with Rare Disease Advocates to Elevate Resources and Shared Experiences Through Launch of #RAREis™ Community Website	PDF Version
08/07/19	Summary Toggle Horizon Therapeutics plc Reports Strong Second-Quarter 2019 Results; Increases Full‐Year 2019 Net Sales and Adjusted EBITDA Guidance	Q2 2019 Earnings Release 401 KB
08/01/19	Summary Toggle Horizon Therapeutics plc Announces Teprotumumab Expanded Access Program	PDF Version
08/01/19	Summary Toggle Horizon Therapeutics plc Appoints Dr. Sue Mahony to Board of Directors	PDF Version
07/25/19	Summary Toggle Horizon Therapeutics plc Wins International CSR Excellence Award for Partnership with Perspectives Math and Science Academy	PDF Version
07/18/19	Summary Toggle Horizon Therapeutics plc Announces U.S. FDA Acceptance of its New Drug Application to Make PROCYSBI® (Cysteamine Bitartrate) Available as Oral Granules in Packets	PDF Version
07/16/19	Summary Toggle Horizon Therapeutics plc to Release Second-Quarter 2019 Financial Results and Host Webcast on Aug. 7, 2019	PDF Version
07/11/19	Summary Toggle Horizon Therapeutics plc Announces Pricing of Private Offering of Senior Notes	PDF Version